Additionally, our predictions point to promising strategies such as targeting DRD2 for tumor suppression and validating Olsalazine and Pizotifen for colorectal cancer through their effects on Wnt signaling and COX1 [57,61]. The gene discussed is DRD2; the disease is neoplasm.